COCH Envoy Medical Inc

  1. Stocks
  2. Healthcare
  3. NASDAQ: COCH

Price (delayed)

$0.722

Market cap

$55.73M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$0.76

Enterprise value

$36.87M

Sign up for free to view scoring metrics ?
Relative Growth: Rel. Growth:
Relative Strength: Rel. Strength:
Relative Valuation: Rel. Valuation:
Relative Profitability: Rel. Profitability: 2
Highlights
The debt has dropped by 97% year-on-year and by 9% since the previous quarter
The EPS has grown by 46% YoY and by 25% from the previous quarter
Envoy Medical's quick ratio has soared by 133% YoY but it has decreased by 25% from the previous quarter
Envoy Medical's equity has soared by 111% YoY but it has plunged by 67% from the previous quarter
Envoy Medical's gross margin has decreased by 47% YoY and by 24% from the previous quarter
The gross profit has declined by 37% year-on-year and by 10% since the previous quarter
Sector: Healthcare
Industry: Medical Devices
Website: https://www.envoymedical.com
Peers: ABT MDT ISRG SYK

Key stats

What are the main financial stats of COCH

COCH stock price

How has the Envoy Medical stock price performed over time
Intraday
0.92%
1 week
1.68%
1 month
-3.73%
1 year
-15.07%
YTD
9.21%
QTD
-8.84%

Financial performance

How have Envoy Medical's revenue and profit performed over time
Revenue
$207,000
Gross profit
-$798,000
Operating income
-$23.62M
Net income
-$23.4M
Gross margin
-385.5%
Net margin
-11,304.8%
Envoy Medical's gross margin has decreased by 47% YoY and by 24% from the previous quarter
The gross profit has declined by 37% year-on-year and by 10% since the previous quarter
Envoy Medical's operating margin has decreased by 29% YoY and by 15% QoQ
COCH's operating income is down by 20% YoY and by 2.2% QoQ

Price vs fundamentals

How does COCH's price correlate with its fundamentals

Growth

What is Envoy Medical's growth rate over time

Valuation

What is Envoy Medical stock price valuation
P/E
N/A
P/B
16.81
P/S
362.88
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
178.09
The EPS has grown by 46% YoY and by 25% from the previous quarter
Envoy Medical's equity has soared by 111% YoY but it has plunged by 67% from the previous quarter
The P/S is 95% higher than the last 4 quarters average of 184.8 but 49% lower than the 5-year quarterly average of 708.4
The revenue has contracted by 12% from the previous quarter and by 7% YoY

Efficiency

How efficient is Envoy Medical business performance
The ROA has grown by 41% YoY and by 19% from the previous quarter
The ROS has contracted by 26% YoY and by 18% from the previous quarter

Dividends

What is COCH's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for COCH.

Financial health

How did Envoy Medical financials performed over time
The company's total assets is 18% higher than its total liabilities
The company's total assets has surged by 142% YoY but it fell by 20% QoQ
Envoy Medical's quick ratio has soared by 133% YoY but it has decreased by 25% from the previous quarter
The debt is 75% smaller than the equity
The company's debt to equity has surged by 178% QoQ and by 126% YoY
Envoy Medical's equity has soared by 111% YoY but it has plunged by 67% from the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.